Related Experiment Video
Updated: Jul 1, 2025
08:01
Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
42.3K
Aβ∗56 is a stable oligomer that impairs memory function in mice.
Peng Liu1,2, Ian P Lapcinski1,2, Chris J W Hlynialuk1,2
1N. Bud Grossman Center for Memory Research and Care, Minneapolis, MN 55455, USA.
Iscience
|March 4, 2024
Summary
Amyloid-beta*56 (Aβ*56) oligomers impair memory. This study biochemically characterized Aβ*56, revealing its distinct peptide compositions across different mouse models, offering insights into Alzheimer
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Amyloid-beta (Aβ) oligomers are implicated in cognitive decline.
- Aβ*56 is a specific soluble Aβ assembly linked to memory deficits.
- The precise molecular composition of Aβ*56 has remained unclear.
Purpose of the Study:
- To confirm the memory-impairing effects of Aβ*56.
- To biochemically characterize the Aβ peptide forms within Aβ*56 across different transgenic mouse models.
- To investigate the structural stability and properties of Aβ*56.
Main Methods:
- Utilized antibodies targeting different Aβ forms and oligomers (A11).
- Employed western blotting, immunoaffinity purification, and size-exclusion chromatography.
- Analyzed brain extracts from Tg2576, 5xFAD, and APP/TTA mouse models.
- Injected Aβ*56 into the hippocampus of wild-type mice.
Main Results:
- Confirmed Aβ*56's memory-impairing properties.
- Determined Aβ*56 composition varies: Aβ(1-40) in Tg2576, Aβ(1-42) in 5xFAD, and both in APP/TTA mice.
- Characterized Aβ*56 as an SDS-stable, water-soluble, non-plaque-dependent oligomer.
Conclusions:
- Aβ*56's molecular composition is model-dependent.
- The stability and specific Aβ forms within Aβ*56 are key to its cognitive effects.
- Aβ*56 is a valuable target for understanding the link between molecular structure and brain function in Alzheimer's disease.
